Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.

Du Y, Su T, Tan X, Li X, Xie J, Wang G, Shen J, Hou J, Cao G.

Gene. 2013 Jan 1;512(1):64-9. doi: 10.1016/j.gene.2012.09.094.

PMID:
23069849
2.
3.

Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.

Safarinejad MR, Shafiei N, Safarinejad S.

Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81. doi: 10.1016/j.clon.2011.03.005.

PMID:
21489764
4.

Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.

Safarinejad MR.

BJU Int. 2011 Sep;108(5):762-70. doi: 10.1111/j.1464-410X.2010.10017.x.

5.

Association of RASSF1A genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients.

Kawai Y, Sakano S, Okayama N, Suehiro Y, Matsuyama H, Hinoda Y.

BJU Int. 2012 Oct;110(7):1070-5. doi: 10.1111/j.1464-410X.2012.11143.x.

6.

Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.

Audenet F, Cancel-Tassin G, Bigot P, Audouin M, Gaffory C, Ondet V, Thibault F, Auribault K, Gazut S, Benhabiles N, Azzouzi AR, Méjean A, Rouprêt M, Cussenot O.

J Urol. 2014 Feb;191(2):487-92. doi: 10.1016/j.juro.2013.07.064.

PMID:
23911636
7.

miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.

Wang Z, Wei M, Ren Y, Liu H, Wang M, Shi K, Jiang H.

Tumour Biol. 2014 Dec;35(12):12127-30. doi: 10.1007/s13277-014-2517-5.

PMID:
25213695
8.

Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.

Siegsmund M, Brinkmann U, Scháffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H.

J Am Soc Nephrol. 2002 Jul;13(7):1847-54.

9.

Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients.

Sakano S, Hinoda Y, Okayama N, Kawai Y, Ito H, Nagao K, Hara T, Matsuyama H.

BJU Int. 2010 Aug;106(3):424-30. doi: 10.1111/j.1464-410X.2009.09107.x.

10.

High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.

Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J.

BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x.

11.

Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study.

Wang G, Hou J, Ma L, Xie J, Yin J, Xu D, Chang W, Tan X, Su T, Zhang H, Cao G.

Cancer Epidemiol. 2012 Apr;36(2):177-82. doi: 10.1016/j.canep.2011.09.006.

PMID:
22000673
12.

PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.

Choi JW, Lee JH, Park HS, Kim YS.

J Clin Pathol. 2011 Oct;64(10):893-7. doi: 10.1136/jclinpath-2011-200182.

PMID:
21725041
13.

The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R.

J Urol. 2009 Aug;182(2):721-7. doi: 10.1016/j.juro.2009.03.081.

PMID:
19539330
14.

CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.

Tupikowski K, Partyka A, Kolodziej A, Dembowski J, Debinski P, Halon A, Zdrojowy R, Frydecka I, Karabon L.

Tissue Antigens. 2015 Nov;86(5):353-61. doi: 10.1111/tan.12671.

PMID:
26403483
15.

VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.

Bruyère F, Hovens CM, Marson MN, d'Arcier BF, Costello AJ, Watier H, Linassier C, Ohresser M.

J Urol. 2010 Oct;184(4):1273-8. doi: 10.1016/j.juro.2010.06.009.

PMID:
20723915
16.
17.

Polymorphisms of DNA repair genes are associated with renal cell carcinoma.

Hirata H, Hinoda Y, Matsuyama H, Tanaka Y, Okayama N, Suehiro Y, Zhao H, Urakami S, Kawamoto K, Kawakami T, Igawa M, Naito K, Dahiya R.

Biochem Biophys Res Commun. 2006 Apr 21;342(4):1058-62.

PMID:
16510122
18.

The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.

Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H.

Clin Cancer Res. 2005 Feb 1;11(3):1190-7.

19.

Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.

Page T, Hodgkinson AD, Ollerenshaw M, Hammonds JC, Demaine AG.

Cancer Genet Cytogenet. 2005 Dec;163(2):151-5.

PMID:
16337858
20.

Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.

Zhuang Q, Qian X, Cao Y, Fan M, Xu X, He X.

J Int Med Res. 2014 Apr;42(2):282-91. doi: 10.1177/0300060513505524.

PMID:
24514433
Items per page

Supplemental Content

Support Center